SARS-CoV-2 Spike RBD Antibody [2196], Unconjugated, Recombinant

Produktübersicht

• Artikelname: SARS-CoV-2 Spike RBD Antibody [2196], Unconjugated, Recombinant
• Artikelnummer: BYT-ORB1274617
• Hersteller Artikelnummer: orb1274617
• Alternativnummer: BYT-ORB1274617-0.1
• Hersteller: Biorbyt
• Kategorie: Antikörper
• Applikation: ELISA
• Spezies Reaktivität: Virus
• Immunogen: Sequenced from human survivors of COVID-19 (SARS-CoV-2). The spike RBD is expressed on the surface of SARS-CoV-2.
• Konjugation: Unconjugated
• Alternative Synonym: Receptor Binding Domain Antibody, SARS-CoV-2 Spike RBD Antibody, sars-cov-2

Produktbeschreibung

SARS-CoV-2 Spike RBD Antibody [2196]

Produkteigenschaften

• Klonalität: Recombinant
• Konzentration: >1.0 mg/ml
• Klon-Bezeichnung: [2196]
• Puffer: This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium, calcium or preservatives added.
• Formulierung: Liquid

Anwendungsbeschreibung

• Anwendungsbeschreibung: Application Notes: ELISA (Quality Tested by ProSci)

Bilder

Coating: Purified Recombinant SARS-CoV-2 Spike NTD (Clone 2146) was coated at concentration of 1 ul/well, 100 ul/well overnight 2-8 °C. Sample: Purified rSARS CoV-2 Trimeric Spike Protein at 0.5 µg/mL and serially diluted (2-fold) to 0.98 ng/ml, 100ul/well for 1 hour at 37 °C. Detection: Anti-SARS-CoV-2 Spike RBD (Clone 2196) conjugated to HRP diluted to 0.1 ug/ml, 100 ul/well for 1 hour at 37 °C. Substrate: TMB, 100 ul/well for 15 min, at room temperature followed by 450 nm stop solution, 50ul/well.